Laura Fejerman, PhD

Associate Professor

Dr. Fejerman focuses on the discovery of genetic and non-genetic factors that contribute to breast cancer risk and prognosis in Latinas. Her past work established a relationship between genetic ancestry and breast cancer risk, where higher European ancestry in U.S. and Mexican Latinas was associated with an increased risk. Her subsequent research has built upon this observation, exploring genetic variants, through admixture mapping and genome-wide association approaches, as well as the possible environmental and lifestyle related factors, and ancestry-gene interactions.

Deborah Grady, MD

Professor in Residence

Deborah Grady, MD, MPH is Professor of Epidemiology and Biostatistics and of Medicine, Vice Chair of the Department of Epidemiology and Director of the UCSF/Mount Zion Women's Health Clinical Research Center and the UCSF Women's Health Faculty Development Program.

Alison Huang, MD

Associate Professor In Res

Dr. Alison Huang is an internal medicine physician and a clinical researcher at the University of California San Francisco, where she conducts epidemiologic and interventional research to advance scientific understanding and improve clinical management of menopause- and aging-related health conditions in women.

Vanessa Jacoby, MD

Ob/Gyn, Reproductive Sciences

Dr. Vanessa Jacoby is an obstetrician gynecologist with a research program focused on surgical gynecology. She has studied long-term health outcomes of hysterectomy and oophorectomy. She is the principal investigator of prospective cohort study of women with BRCA1 or BRCA2 mutations who undergo risk-reducing salpingo-oophorectomy funded by the American Cancer Society. Most recently, her research has focused on studies of new minimally invasive treatments for women with uterine fibroids.

Alka Kanaya, MD

Professor In Residence

I have focused my clinical research in the field of type 2 diabetes and obesity and have developed a three-pronged research program that is unified under this theme. The first arm consists of using existing cohort studies to test novel biomarkers that predict diabetes and cardiovascular disease. The second arm is to create a South Asian cohort to study these risk factors in a very high risk group. The final arm is to test behavioral interventions to prevent the onset of diabetes.

Karla Kerlikowske, MD


Dr. Karla Kerlikowske is Professor of Medicine and Epidemiology and Biostatistics at UCSF, Co-Director of the Women’s Clinic and Director of the Women’s Health Fellowship at the San Francisco Veterans Affairs Medical Center. Her clinical research focuses on cancer epidemiology including studies of breast imaging, breast cancer risk assessment, breast density and epidemiology of invasive breast cancer and DCIS.

Eric Vittinghoff, PhD

Adjunct Professor
Epidemiology & Biostatistics